INmune Bio Inc (INMB) stock news · $33.5M cap
INmune Bio Inc (INMB) is a biotechnology company listed on US.
This INMB news page leads with what INmune Bio Inc filed — not a scraped headline mill.
No cached 8-K sentence for INMB yet. We will not pad this page with generic market recap.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the INMB stock page; for the tape open the quote page.
INMB stock news FAQ
What are INMB's latest revenue and net income?
Latest cached INmune Bio Inc (INMB) revenue for Sep 30, 2025 was $50.0K. Net income was -$6.5M. Statements: https://lician.com/financials/inmb
How did INMB revenue change from the prior cached period?
Cached INmune Bio Inc (INMB) revenue was unchanged from $50.0K (Jun 30, 2025) to $50.0K (Sep 30, 2025). Statements: https://lician.com/financials/inmb
What is INMB's market cap?
INmune Bio Inc (INMB) market cap is $33.5M on the latest cached fundamentals snapshot.
What kind of company is INMB?
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Where is INMB stock news listed?
Cached stock news for INmune Bio Inc (INMB) is listed at https://lician.com/news/inmb. Filings: https://lician.com/sec/inmb
Not investment advice.